EUVIMEDEUVIMED entdecken
Crossref

Evaluation of Oligo-Fucoidan as a potentially beneficial adjunct to BNCT in a novel oral cancer and precancer experimental model

Mónica A Palmieri, Jessica A Goldfinger, Paula S Ramos, Agustina M Portu, Julia S Viglietti, Emiliano C C Pozzi, Silvia I Thorp, Paula Curotto, Juan S Guidobono, Marcela A Garabalino, Verónica A Trivillin, Amanda E Schwint und 1 weitere

Radiation and Environmental Biophysics · 2025

DOI: 10.1007/s00411-025-01141-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Radiation and Environmental Biophysics, 2025. Verfasst von Mónica A Palmieri und 12 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Biodiversidad y Biología Experimental (DBBE), Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires (UBA), Buenos Air…. Hauptthemen laut MEDLINE: Polysaccharides, Boron Neutron Capture Therapy, Mouth Neoplasms, Precancerous Conditions. Die Arbeit nennt 70 Literaturangaben. Gefördert von: Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación, National Atomic Energy Commission, Hi-Q Marine Biotech International Ltd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The high mortality and morbidity of Head and Neck cancer patients and the toxicity associated to oncological treatments suggest the need for more selective and non-toxic therapies. BNCT (Boron Neutron Capture Therapy) is based on the capture reaction between boron-10, selectively targeted to tumor tissue, and a thermal neutron. In this study, an oral cancer and precancer model was used to study the therapeutic effect and radiotoxicity of BNCT mediated by BPA (boronphenylalanine) [BPA-BNCT] at short and medium-term follow-up. Oligo-Fucoidan, an extract of Laminaria japonica brown seaweed, was evaluated as a potentially beneficial adjunct to BPA-BNCT. Hamsters were chemically cancerized over 8 weeks. Tumor bearing hamsters were assigned to: (CONTROL) cancerized, sham-irradiated group; BPA-BNCT 3 Gy absorbed dose to precancerous tissue; BPA-BNCT 3 Gy + Oligo-Fucoidan (200 mg/kg/day, for 16 days). Neutron irradiation was performed at the RA-3 Nuclear Reactor 3 h post administration of BPA (15.5 mg 10B/kg). Boron biodistribution and microdistribution studies were performed in BPA and BPA + Oligo-Fucoidan groups. Oligo-Fucoidan did not reduce either the incidence of moderate/severe mucositis or reduced the percentage of animals with new tumors in precancerous tissue. Oligo-Fucoidan did enhance BPA-BNCT-induced tumor response at one month (67-94%) and three months after BNCT (42-81%). To understand this effect, boron biodistribution and microdistribution studies were performed. They demonstrated a slight tendency of Oligo-Fucoidan to increase boron concentration in tumors. Oligo-Fucoidan, used in humans and clinical veterinary patients, would be a potentially beneficial adjunct to BNCT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PolysaccharidesBoron Neutron Capture TherapyMouth NeoplasmsPrecancerous ConditionsAnimalsCricetinaeDisease Models, AnimalMaleFemaleMucositisEdible SeaweedsLaminaria

Stichwörter der Autor:innen

BNCT in vivoBiodistributionMicrodistributionOligo-FucoidanOral cancer and precancer model

Substanzen

fucoidanPolysaccharides

Autor:innen und Institutionen

  • Departamento de Biodiversidad y Biología Experimental (DBBE), Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires (UBA), Buenos Aires, Intendente Güiraldes 2160, Ciudad Universitaria, C1428EGA, CABA, A…
  • Dpto. Radiobiología, Centro Atómico Constituyentes, Comisión Nacional de Energía Atómica (CNEA), Av. General Paz 1499, Provincia de Bs.As, San Martín, B1650KNA, Argentina.
  • Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.
  • Departmento de Reactores de Investigación y Producción, Centro Atómico Ezeiza (CAE), CNEA, Camino Real Presbítero González y Aragón 15, B1802AYA Ezeiza, Provincia de Bs.As, Ezeiza, Argentina.
  • Sub-gerencia Instrumentación y Control, CAE, CNEA, Camino Real Presbítero González y Aragón 15, B1802AYA Ezeiza, Provincia de Bs.As, Buenos Aires, Argentina.
  • Instituto de Ecología, Genética y Evolución de Buenos Aires (IEGEBA), CONICET, UBA; Intendente Güiraldes 2160, Ciudad Universitaria, Ciudad Autónoma de Buenos Aires, C1428EGA, CABA, Argentina.

Förderung

  • Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación
  • National Atomic Energy Commission
  • Hi-Q Marine Biotech International Ltd

Zitieren

APA

Palmieri, M. A., Goldfinger, J. A., Ramos, P. S., Portu, A. M., Viglietti, J. S., Pozzi, E. C. C., Thorp, S. I., Curotto, P., Guidobono, J. S., Garabalino, M. A., Trivillin, V. A., Schwint, A. E., & Monti Hughes, A. (2025). Evaluation of Oligo-Fucoidan as a potentially beneficial adjunct to BNCT in a novel oral cancer and precancer experimental model. Radiation and Environmental Biophysics. https://doi.org/10.1007/s00411-025-01141-3

Vancouver

Palmieri MA, Goldfinger JA, Ramos PS, Portu AM, Viglietti JS, Pozzi ECC, et al. Evaluation of Oligo-Fucoidan as a potentially beneficial adjunct to BNCT in a novel oral cancer and precancer experimental model. Radiation and Environmental Biophysics. 2025. doi:10.1007/s00411-025-01141-3

BibTeX
@article{Palmieri2025,
  author = {Palmieri, Mónica A and Goldfinger, Jessica A and Ramos, Paula S and Portu, Agustina M and Viglietti, Julia S and Pozzi, Emiliano C C and Thorp, Silvia I and Curotto, Paula and Guidobono, Juan S and Garabalino, Marcela A and Trivillin, Verónica A and Schwint, Amanda E and Monti Hughes, Andrea},
  title = {Evaluation of Oligo-Fucoidan as a potentially beneficial adjunct to BNCT in a novel oral cancer and precancer experimental model},
  journal = {Radiation and Environmental Biophysics},
  year = {2025},
  doi = {10.1007/s00411-025-01141-3}
}
Kostenlos starten →